[123I]Metaiodobenzylguanidine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [123I]Metaiodobenzylguanidine, covering 2025-07-21 to 2025-07-21. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma